share_log

Foresight Acquisition, P3 Health Partners Announce Adjournment Of Special Meeting For Proposed Business Combination Until Nov. 24

Foresight Acquisition, P3 Health Partners Announce Adjournment Of Special Meeting For Proposed Business Combination Until Nov. 24

Foresight Acquisition,P3 Health Partners宣佈擬議的業務合併特別會議休會至11月24日
Benzinga Real-time News ·  2021/11/19 00:04

Foresight Acquisition Corp. (NASDAQ:FORE) ("Foresight") announced that its Special Meeting of Foresight's stockholders (the "Special Meeting") relating to the proposed business combination (the "Business Combination") with P3 Health Partners ("P3") was convened today at 9:00 a.m. Central Time and adjourned until 7:00 a.m. Central Time on November 24, 2021. The Special Meeting was adjourned to give Foresight's stockholders additional time to consider additional disclosure to be included in a supplement to the Proxy Statement that was filed with the Securities and Exchange Commission ("SEC") on October 28, 2021 (the "Proxy Statement") and mailed to Foresight's stockholders, including expected changes to certain pro forma financial information related to the determination that the Business Combinations should be accounted for as a business combination using purchase accounting adjustments rather than as a reverse recapitalization as currently provided for in the Unaudited Pro Forma Financial Statements in the Proxy Statement.  These changes will have no impact on the historical financial statements of P3 or Foresight that were included in the Proxy Statement. Foresight expects to file a supplement to the Proxy Statement on or prior to Monday, November 22, 2021.
 

亞洲網加利福尼亞州聖克拉拉3月22日電納斯達克(Temasek Holdings:FOREL)(以下簡稱“FORESING”)宣佈,與P3健康夥伴公司(P3 Health Partners)擬進行的業務合併(“業務合併”)有關的FORESIGN公司股東特別大會(下稱“特別會議”)已於今天上午9點召開。中部時間,休會至上午7點。中部時間2021年11月24日。特別會議延期是為了讓Foresight的股東有更多的時間考慮將在2021年10月28日提交給美國證券交易委員會(“美國證券交易委員會”)並郵寄給Foresight股東的委託書附錄(“委託書”)中包括額外的披露,包括與確定業務合併應作為使用購買會計調整的業務合併而不是作為當前未經審計的備考財務報表中規定的反向資本重組相關的某些備考財務信息的預期變化。這些變化不會對委託書中包含的P3或Foresight的歷史財務報表產生影響。Presight預計將在2021年11月22日(星期一)或之前提交委託書的附錄。

No changes have been made to the record date, the location of the meeting or the proposals to be voted on at the Special Meeting, which are presented in Foresight's Proxy Statement filed with the Securities and Exchange Commission on October 28, 2021. The re-convened meeting will be held virtually at https://www.cstproxy.com/foresightacq/2021Only the holders of Foresight's common stock as of the close of business on October 8, 2021, the record date for the Special Meeting, are entitled to vote at the Special Meeting.

記錄日期、會議地點或將在特別會議上投票的提案沒有任何變化,這些都在Foresight於2021年10月28日提交給美國證券交易委員會(Securities And Exchange Commission)的委託書中提出。重新召開的會議實際上將在下午6點舉行。Https://www.cstproxy.com/foresightacq/2021. 只有截至2021年10月8日,也就是特別會議的創紀錄日期收盤時,Foresight公司普通股的持有者才有權在特別會議上投票。

If you have already submitted your proxy, you do not need to take any action unless you wish to change your vote. You retain the power to revoke your proxy or change your vote at any time before it is voted at the Special Meeting on November 24, 2021. Only the most recent proxy vote will be counted and all others will be discarded regardless of the method of voting. If a broker or other nominee holds your stock on your behalf, you must contact your broker, bank or other nominee to change your vote. As a result of the adjournment, Foresight stockholders will be able to continue to change their redemption election on or prior to 5:00 Eastern Time on Monday, November 22, 2021.

如果你已經提交了你的委託書,你不需要採取任何行動,除非你想改變你的投票。您保留在2021年11月24日的特別會議上投票前的任何時間撤銷您的委託書或更改您的投票的權力。無論採用何種投票方式,都將只計算最近的代理投票,其他所有投票都將被丟棄。如果經紀人或其他被提名人代表您持有您的股票,您必須聯繫您的經紀人、銀行或其他被提名人來更改您的投票。休會的結果是,Foresight股東可以在美國東部時間2021年11月22日(星期一)下午5點或之前繼續更改他們的贖回選擇。

If the proposals at the Special Meeting are approved, the parties anticipate that the Business Combination will close as promptly as practicable after the meeting, subject to the satisfaction or waiver (as applicable) of all other closing conditions.

如果特別會議上的建議獲得批准,雙方預計業務合併將在會議結束後儘快結束,但須滿足或豁免(視情況適用)所有其他結束條件。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論